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Abstract
Background: To evaluate the modulation indices (MIs) for predicting the plan delivery accuracies of intensity-
modulated radiation therapy (IMRT) plans.
Methods: A total of 100 dynamic IMRT plans that used TrueBeam STx and 102 dynamic IMRT plans that used
Trilogy were selected. For each plan, various MIs were calculated, which included the modulation complexity score
(MCS), plan-averaged beam area (PA), plan-averaged beam irregularity (PI), plan-averaged beam modulation (PM),
MI quantifying multi-leaf collimator (MLC) speeds (MIs), MI quantifying MLC acceleration (MIa), and MI quantifying
MLC acceleration and segment aperture irregularity (MIc,IMRT). To determine plan delivery accuracy, global gamma
passing rates, MLC errors of log files, and dose-volumetric parameter differences between original and log file-
reconstructed IMRT plans were obtained. To assess the ability of each MI for predicting plan delivery accuracy,
Spearman’s rank correlation coefficients (rs) between MIs and plan delivery accuracy measures were calculated.
Results: PI showed moderately strong correlations with gamma passing rates in MapCHECK2 measurements of
both TrueBeam STx and Trilogy (rs = − 0.591 with p < 0.001 and − 0.427 with p < 0.001 to with gamma criterion of
2%/2 mm, respectively). For ArcCHECK measurements, PI also showed moderately strong correlations with the
gamma passing rates in the ArcCHECK measurements of TrueBeam STx and Trilogy (rs = − 0.545 with p < 0.001 and
rs = − 0.581 with p < 0.001 with gamma criterion of 2%/2 mm, respectively). The PI showed the second strongest
correlation with MLC errors in both TrueBeam STx and Trilogy (rs = 0.861 with p < 0.001 and rs = 0.767 with p < 0.
001, respectively). In general, the PI showed moderately strong correlations with every plan delivery accuracy
measure.
Conclusions: The PI showed moderately strong correlations with every plan delivery accuracy measure and
therefore is a useful predictor of IMRT delivery accuracy.
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Background
Intensity-modulated radiation therapy (IMRT) delivers
highly conformal radiation dose distributions to target
volumes, while sparing normal tissues [1–8]. As the
IMRT plan complexity increases to acquire the desired
dose distribution, i.e., the modulation degree of IMRT
increases, a large number of small and irregularly shaped
beam apertures are utilized. It results in increased dose
calculation and multi-leaf collimator (MLC) movement
uncertainties [4, 9–11]. Therefore, the probability that
the intended dose distribution is not accurately delivered
to the patient during treatment increases. In this respect,
verification of IMRT plan delivery accuracy is highly rec-
ommended before treatment in a clinical setting.
To verify IMRT plan delivery accuracy, gamma evalu-
ations have been widely adopted in the clinic, as
pre-treatment quality assurance (QA) methods [12–14].
Although gamma evaluation is a practical method, it
has some limitations. It has been reported that the
gamma passing rates of individual dosimeters have been
inconsistent with respect to each other [15]. Therefore,
a thorough gamma evaluation validation of each device
that is installed in the clinic should be performed.
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Moreover, recent studies have demonstrated the clinical
irrelevance of the gamma passing rates [16–18]. As an
alternative to the gamma evaluation, an analysis of the
machine log files that are recorded during delivery has
been recommended as a pre-treatment QA by several
studies [19–22]. This method can be expanded to
analyze the differences between dose-volume parame-
ters of the original plan and the plans that are recon-
structed with machine log files [23–25]. However, this
method has limitations, as it does not provide an inde-
pendent verification of linac beam delivery.
On the other hand, to predict IMRT delivery accuracy
and calculate the complexity of IMRT plans, several
studies have introduced modulation indices (MIs) [4,
10, 26, 27]. Webb et al. measured the modulation de-
gree of IMRT plans by quantifying the changes of adja-
cent beamlets that exceeded a pre-defined tolerance
levels, derived with standard deviations of the fluence
map [10]. McNiven et al. designed modulation com-
plexity score (MCS) quantifications of beam aperture
and MLC position variations. The MCSs were found to
vary from 0 to 1 and decreased as the IMRT plan
modulation degrees increased [27]. Du et al. quantified
the complexities of both the IMRT and volumetric
modulated arc therapy (VMAT) plans, using the beam
aperture areas and perimeters, to quantify the usage of
small and irregularly shaped beam apertures [4]. For
VMAT, Park et al. expanded the concept of Webb’s MI
to comprehensively assess MLC speeds and accelera-
tions, the variation of gantry rotation speed, the vari-
ation of dose-rate, and the usage of small and
irregularly shaped beam apertures [26].
Previous studies have investigated the performance of
several MIs for predicting IMRT delivery accuracy,
through the use of correlation analyses on conventional
plan delivery accuracy measures, such as gamma pass-
ing rates. However, there are limitations to evaluating
MIs with a single type of linac, single photon energy,
limited treatment sites, or using a single type of meas-
uring device. Therefore, further studies need to evaluate
the performance of various MIs that are used as clinical
predictors of IMRT plan deliveries. In this study, we
assessed the performances of various MIs that have
been suggested by previous studies to predict IMRT
plan delivery accuracy with correlation analyses.
Methods
Patient selection and IMRT planning
Two machines, Trilogy and TrueBeam STx (Varian
Medical Systems, Palo Alto, CA), which have different
plan delivery systems and machine log file generation
systems, were selected for this study. After approval by
the institutional review board (IRB), a total of 181 pa-
tients with various treatment sites were retrospectively
selected, and a total of 202 dynamic IMRT plans were
generated for this study.
With the TrueBeam STx system, a total of 100 dy-
namic IMRT plans were generated for head and neck
(HN) cancer (20 cases), brain tumor (20 cases), liver
cancer (20 cases), spine tumor (20 cases), and lung can-
cer (20 cases). For HN cancer, a simultaneous integrated
boost (SIB) technique was applied. For liver cancer, spine
tumors, and lung cancer, stereotactic ablative radiother-
apy (SABR) was performed using flattening filter free
(FFF) photon beams of 6 MV (6 FFF) and 10 FFF. With
Trilogy, a total of 102 dynamic IMRT plans were gener-
ated for HN cancer (40 cases), prostate cancer (21 pri-
mary plans and 21 boost plans), liver cancer (11 cases),
and spine tumor (9 cases). The HN IMRT plans were
generated with the SIB technique as with TrueBeam STx
system. Information of IMRT plans generated in this
study is summarized in Additional file 1: Table S1.
Every IMRT plan in this study was generated in
Eclipse™ (Varian Medical Systems, Palo Alto, CA). All
IMRT plans used in this study were optimized with the
dose volume optimizer (DVO, ver. 10, Varian Medical
Systems, Palo Alto, CA), and the dose distributions
were calculated using the anisotropic analytic algorithm
(AAA, ver. 10, Varian Medical Systems, Palo Alto, CA),
with a calculation grid of 1 mm. All IMRT plans were
normalized to cover 100% of the target volumes with
90% of the prescription doses.
Calculation of IMRT plan modulation indices
For each IMRT plan, the MCS from McNiven et al.; the
plan-averaged beam area (PA), plan-averaged beam ir-
regularity (PI), and plan-averaged beam modulation
(PM) from Du et al.; the modulation index quantifying
the speed of MLC (MIs); the modulation index for
quantifying the MLC acceleration (MIa); and the modu-
lation index for quantifying the MLC acceleration and
aperture irregularity of the IMRT plan (MIc,IMRT) were
calculated. Although MIc,IMRT values were originally de-
signed for VMAT, we modified these indices to con-
sider only MLC movements for application to IMRT
plans. In other words, we excluded gantry rotation ac-
curacy and dose-rate variability evaluations from the
MIc,IMRT value. To eliminate the influence of various
segment numbers on the MCS, MIs, MIa, and MIc,IMRT
values, we normalized the values of these MIs with the
total segment numbers. Equations of the MIs that were
calculated in this study (including modifications) are
summarized in Additional file 1: Table S2.
Measures of IMRT plan delivery accuracy
To evaluate plan delivery accuracy, three types of IMRT
plan verification methods were used in this study,
which included the global gamma evaluation with
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absolute doses, differences in MLC positions between
planned and the actual deliveries utilizing machine log
files, and the differences in the dose-volumetric param-
eters that were calculated from the original IMRT plans
and from the IMRT plans that were reconstructed with
machine log files.
For global gamma evaluation, reference dose distribu-
tions were calculated in the Eclipse system, with a calcula-
tion grid size of 1 mm. The calculated dose distributions
were compared to the measured dose distributions using
MapCHECK2™ and ArcCHECK™ detector arrays (Sun Nu-
clear Corporation, Melbourne, FL). Global gamma evalua-
tions with gamma criteria of 3%/3mm, 2%/2mm, 2%/1
mm, and 1%/2mm were performed with absolute doses.
Percent dose differences in the global gamma evaluation
were calculated relative to the maximum dose in the cal-
culated dose distribution. Before the gamma evaluation
measurements, MapCHECK2 and ArcCHECK dosimeters
were calibrated, according to manufacturer guidelines.
When IMRT plans were delivered to the dosimeters for
gamma evaluation, the actual MLC positions and deliv-
ered monitor units (MUs) at each segment were obtained
from the DynaLog (Trilogy) and Trajectory (TrueBeam
STx) files. These log files were reconstructed as
DICOM-RT files, using an in-house program that was
written in MATLAB (R2016a, Mathworks Inc., Natick,
MA). The differences in the MLC positions between the
original IMRT plan and the actual delivery were calculated
and averaged for each IMRT plan. After the reconstructed
DICOM-RT files from the log files were imported in the
Eclipse system, dose distributions were calculated with the
same dose calculation condition of the original IMRT
plan. With the dose distributions calculated from re-
constructed IMRT plans, dose-volumetric parameters
for the target volumes and organs at risk (OARs) were
calculated and compared to those of the original IMRT
plans. The total number of analyzed dose volumetric
parameters of TrueBeam STx and Trilogy were 156 and
152, respectively.
Correlation analysis
To evaluate the performance of each MI that was calcu-
lated in this study as an indicator of IMRT delivery ac-
curacy, Spearman’s rho (rs) and corresponding p values
were calculated between the MIs and the IMRT deliv-
ery accuracy measures. In the correlation analysis of
different dose-volumetric parameters, the sample sizes
were different from one another and the numbers of
analyzed dose-volumetric parameters were large. For
these reasons, we only counted the number of rs values
with corresponding p values less than 0.05, which were
considered as statistically significant in this study. The
correlations with rs values from 0.2 to 0.39 are regarded
as weak correlations. Those from 0.4 to 0.59 and 0.6 to
1 are regarded as moderately strong and very strong
correlations, respectively [27, 28].
Results
The values of modulation indices
The values of MIs are shown in Table 1. The values of
MIs showed various tendencies, depending on the type
of linac and treatment sites.
Measurement of plan delivery accuracies
The global gamma passing rates with gamma criteria of
3%/3 mm, 2%/2 mm, 2%/1 mm, and 1%/2 mm are
shown in Table 2. The mean gamma passing rate for
each treatment site was remarkably different from one
another at gamma criteria of 2%/1 mm and 1%/2 mm.
The differences between the planned and actual MLC
positions are shown in Fig. 1. The average MLC differ-
ences of TrueBeam STx and Trilogy were 0.06 mm and
0.25 mm, respectively. For TrueBeam STx, the average
MLC difference of the brain IMRT plans was the high-
est, at 0.13 mm, while for Trilogy, the average MLC dif-
ference of the HN IMRT plans was the highest (0.37
mm). The MLC errors of TrueBeam STx were much
smaller than those of the Trilogy system.
Correlations between gamma passing rates and modulation
indices
The rs values of MIs for the global gamma passing
rates, with gamma criteria of 3%/3 mm, 2%/2 mm, 2%/
1 mm and 1%/2 mm, of the TrueBeam STx and Trilogy
systems are shown in Tables 3 and 4, respectively. The
results presented the rs values with statistically signifi-
cant p values less than 0.05.
Correlations between differences in machine parameters
and modulation indices
The correlations between MLC errors and various MIs
are shown in Table 5. For TrueBeam STx, every MI
showed statistically significant correlations with MLC
errors, except for MCS and PM. For Trilogy, every MI
showed statistically significant correlations with MLC
errors. The PI value had rs values of 0.861 and 0.767 in
both the TrueBeam STx and Trilogy systems, respect-
ively, showing the second strongest correlation (all
with p < 0.001).
Correlations between differences in dose-volume
parameters and modulation indices
The numbers of statistically significant rs values (p < 0.05)
of the various MIs to the differences in dose-volumetric
parameters between original and reconstructed IMRT
plans are shown in Fig. 2. The PI showed statistically
significant rs values most frequently in the TrueBeam
STx system (26 cases), whereas the PM showed
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statistically significant rs values most frequently in the
Trilogy system (37 cases).
Discussion
In this study, we calculated the various MIs that have
been previously suggested to predict IMRT delivery ac-
curacy and then evaluated the performances of the MIs.
When reviewing the mean values of MIs comprehen-
sively, they showed inconsistent trends in IMRT plan
complexities for the type of linac and treatment sites.
This is because that the factors to be considered when
calculating the values of MIs were different from one
another. The MCS, PA, PI, and PM indices mainly
focus on the beam aperture irregularity or the degree of
segmentation, whereas the MIs, MIa, and MIc, IMRT in-
dices mainly focus on the degree of mechanical move-
ments. Nevertheless, for both the TrueBeam STx and
Trilogy systems, all MIs except for the MIs and PA in-
dices, indicated that the HN IMRT had the first or sec-
ond highest complexity. The MIs values seem to have a
limitation to calculate the plan complexities properly
for various treatment sites since only MLC movements
were considered for the MIs. The PA values increased
as the modulation degree of IMRT increased unlike the
Table 1 The average values of various modulation indices for intensity modulated radiation therapy plans
MIs (× 10
− 3) MIa (× 10
− 2) MIc, IMRT (× 10
− 1) MCS (× 10− 1) PA (× 10− 1) PI (× 10− 1) PM
TrueBeam STx
Lung SABR (n = 20) 7.97 ± 1.41 2.67 ± 0.69 0.31 ± 0.08 1.25 ± 0.18 1.01 ± 0.45 0.73 ± 0.18 0.67 ± 0.05
Spine SABR (n = 20) 5.62 ± 1.48 1.46 ± 0.48 0.17 ± 0.05 0.64 ± 0.19 1.13 ± 0.53 1.53 ± 1.35 0.86 ± 0.05
Liver SABR (n = 20) 7.83 ± 2.46 2.40 ± 0.60 0.27 ± 0.06 1.11 ± 0.42 1.39 ± 0.67 1.03 ± 0.65 0.73 ± 0.12
Brain (n = 20) 9.20 ± 2.56 9.06 ± 2.62 1.01 ± 0.28 1.40 ± 0.46 3.72 ± 1.85 0.70 ± 0.27 0.67 ± 0.13
Head and neck (n = 20) 6.12 ± 2.24 7.06 ± 1.52 0.82 ± 0.17 0.35 ± 0.08 3.72 ± 0.82 2.30 ± 0.43 0.93 ± 0.02
Trilogy
Head and neck (n = 40) 4.14 ± 1.11 5.94 ± 0.83 0.70 ± 0.10 0.30 ± 0.05 2.27 ± 0.41 1.87 ± 0.22 0.94 ± 0.01
Prostate primary (n = 21) 3.34 ± 0.71 4.95 ± 0.79 0.58 ± 0.09 0.81 ± 0.14 0.95 ± 0.22 0.64 ± 0.11 0.79 ± 0.04
Prostate boost (n = 21) 3.18 ± 0.43 4.89 ± 0.65 0.57 ± 0.07 0.94 ± 0.13 0.90 ± 0.14 0.47 ± 0.10 0.72 ± 0.04
Liver (n = 11) 5.14 ± 2.14 6.93 ± 1.40 0.80 ± 0.16 0.78 ± 0.24 1.72 ± 0.60 0.94 ± 0.54 0.79 ± 0.07
Spine (n = 9) 5.46 ± 2.68 4.02 ± 1.55 0.47 ± 0.17 0.63 ± 0.25 2.01 ± 1.40 1.26 ± 0.82 0.86 ± 0.06
Note: MIs Modulation index considering multi-leaf collimator speed, MIa Modulation index considering multi-leaf collimator acceleration, MIc, IMRT Modulation index
considering multi-leaf collimator acceleration and field aperture irregularity for intensity modulated radiation therapy, MCS Modulation complexity score, PA Plan-
averaged beam area, PI Plan-averaged beam irregularity, PM Plan-averaged beam modulation, SABR Stereotactic ablative radiotherapy, Prostate primary Prostate
primary plan, Prostate boost Prostate boost plan
Table 2 Average values of global gamma passing rates of intensity modulated radiation therapy plans
3%/3 mm 2%/2 mm 2%/1 mm 1%/2 mm
MC AC p MC AC p MC AC p MC AC p
TrueBeam
Lung SABR (n = 2) 98.5 ± 2.3 99.4 ± 0.6 < 0.001 93.8 ± 4.0 97.7 ± 1.7 < 0.001 85.3 ± 7.1 91.1 ± 3.6 < 0.001 75.2 ± 11.7 95.9 ± 2.7 < 0.001
Spine SABR (n = 20) 98.4 ± 2.7 99.3 ± 0.9 < 0.001 95.8 ± 4.1 97.9 ± 1.5 < 0.001 91.0 ± 7.1 87.6 ± 4.3 0.047 91.1 ± 4.3 95.6 ± 2.6 < 0.001
Liver SABR (n = 20) 99.2 ± 0.9 99.4 ± 1.2 < 0.001 96.7 ± 2.4 97.9 ± 3.1 < 0.001 92.7 ± 4.0 88.8 ± 7.3 0.013 91.1 ± 5.3 95.8 ± 4.7 < 0.001
Brain (n = 20) 98.8 ± 1.6 99.3 ± 2.4 0.002 96.4 ± 3.3 98.5 ± 4.2 0.002 91.6 ± 4.7 92.1 ± 7.3 0.761 89.8 ± 7.1 97.2 ± 4.9 < 0.001
Head and neck
(n = 20)




99.4 ± 0.6 99.8 ± 0.7 0.088 96.3 ± 2.4 98.5 ± 2.1 < 0.001 90.1 ± 3.9 94.4 ± 3.7 0.003 87.8 ± 5.3 94.8 ± 3.9 < 0.001
Prostate primary
(n = 21)
98.2 ± 0.8 99.5 ± 0.4 0.162 93.9 ± 1.4 97.1 ± 1.0 0.042 84.8 ± 3.0 86.1 ± 2.7 0.077 85.4 ± 1.7 93.4 ± 1.8 < 0.001
Prostate boost
(n = 21)
97.3 ± 1.5 99.4 ± 0.5 0.624 89.4 ± 2.6 96.2 ± 1.9 0.187 78.9 ± 5.0 83.6 ± 4.9 0.043 73.1 ± 4.9 92.5 ± 2.9 0.005
Liver (n = 11) 99.2 ± 0.8 99.8 ± 0.2 0.418 97.3 ± 2.6 98.2 ± 1.4 0.083 93.9 ± 3.9 92.3 ± 4.2 0.814 90.4 ± 4.1 94.5 ± 2.9 < 0.001
Spine (n = 9) 99.2 ± 0.9 99.7 ± 0.4 0.246 96.4 ± 3.4 97.3 ± 1.6 0.152 91.5 ± 6.6 89.3 ± 6.8 0.135 91.0 ± 5.5 92.5 ± 2.5 0.153
Note: MC MapCHECK2™ detector array, AC ArcCHECK™ detector array, SABR Stereotactic ablative radiotherapy, Prostate primary Prostate primary plan,
Prostate boost Prostate boost plan
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existing definition and this was caused by the various
target volume sizes for each treatment site in this study.
Since the PA regards the use of small-sized apertures as
high modulation of a plan, it is not appropriate to
evaluate modulation degree of plans with various treat-
ment sites. For example, the target volume sizes of the
HN IMRT plans, which were highly modulated, were
the largest among all IMRT plans, which resulted in the
highest value of PA (the high value of PA means low
modulation of a plan by its definition). On the contrary,
the target volume sizes of the prostate boost IMRT
plans, which were modulated less, were small, which
resulted in the lowest value of PA. Therefore, PA in-
creased owing to the target volume size variations not
the modulation degree in this study. If we analyzed
IMRT plans of a single treatment site with similar tar-
get volume sizes, this contradictory tendency to the
definition of the PA would not be observed [26, 29].
PA values seem to not provide an appropriate modu-
lation index for predicting IMRT delivery accuracy,
through our analysis of IMRT plans with various
treatment sites.
For TrueBeam STx, every gamma passing rate with
both the MapCHECK2 and ArcCHECK indicated that
HN IMRT plans had the lowest gamma passing rates
for all gamma criteria. For Trilogy, every gamma pass-
ing rate with both the MapCHECK2 and ArcCHECK
indicated that prostate boost plans had the lowest
gamma passing rates for all gamma criteria, showing
the inconsistency with the tendencies in the values of
MIs. It was indicated that high-dose gradients of the
field edge with low modulation and small field sizes in-
creased the measurement uncertainty [30, 31] and it
seems to decrease the gamma passing rates. This may
Fig. 1 Average and standard deviation of differences in MLC
positions between the treatment plans and log files are shown. Dark
gray bars represent intensity-modulated radiation therapy (IMRT)
plans of TrueBeam STx (TBX) and light gray bars represent IMRT
plans of Trilogy (TRG)
Table 3 Correlations between global gamma passing rates with various gamma criteria and the modulation indices for intensity
modulated radiation therapy plans of TrueBeam STx (p ≤ 0.05)
3%/3mm 2%/2mm 2%/1mm 1%/2mm
rs p rs p rs p rs p
MapCHECK2
MIs − 0.241 0.016 − 0.200 0.046 – – – –
MIa – – – – – – – –
MIc, IMRT – – – – – – − 0.201 0.045
MCS 0.453 < 0.001 0.548 < 0.001 0.509 < 0.001 0.460 < 0.001
PA −0.223 0.026 − 0.236 0.018 – – − 0.196 0.050
PI −0.465 < 0.001 −0.591 < 0.001 − 0.550 < 0.001 − 0.474 < 0.001
PM − 0.476 < 0.001 − 0.566 < 0.001 − 0.516 < 0.001 − 0.438 < 0.001
ArcCHECK
MIs − 0.375 < 0.001 − 0.341 0.001 −0.518 < 0.001 − 0.292 0.003
MIa −0.234 0.019 – – − 0.234 0.019 – –
MIc, IMRT −0.225 0.025 – – −0.228 0.022 – –
MCS 0.431 < 0.001 0.593 < 0.001 0.451 < 0.001 0.699 < 0.001
PA −0.235 0.019 – – − 0.225 0.024 – –
PI −0.340 0.001 −0.545 < 0.001 −0.328 0.001 −0.677 < 0.001
PM −0.369 < 0.001 −0.545 < 0.001 − 0.389 < 0.001 − 0.667 < 0.001
Note: rs Spearman’s rho, MIs Modulation index considering multi-leaf collimator speed, MIa Modulation index considering multi-leaf collimator acceleration, MIc, IMRT
Modulation index considering multi-leaf collimator acceleration and field aperture irregularity for intensity modulated radiation therapy, MCS Modulation
complexity score, PA Plan-averaged beam area, PI Plan-averaged beam irregularity, PM Plan-averaged beam modulation
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be a factor in lowering correlations between MIs and
gamma passing rates. Even for identical IMRT plan de-
liveries under identical gamma parameter settings, we
acquired different gamma passing rates between the
MapCHECK2 and ArcCHECK dosimeters, similar the
findings of a previous study [15, 31]. Because the Map-
CHECK2 dosimeter has a high angular dependency, the
gamma passing rates become inaccurate when the
weight of delivered MUs increase at gantry angles near
90° or 270°. Jin et al. demonstrated that the Map-
CHECK2 measured doses near a gantry angle of 90°
were inaccurate, and the inaccuracy increased as the
photon beam energy decreased (30.6, 8.9, and 2.2% at
gantry angles of 90° ± 10° for photon beam energies of
6, 10, and 15 MV, respectively) [30, 31]. Similarly, dif-
ferences in the gamma passing rates between two do-
simeters were large for lung SABR of the TrueBeam
STx system, which used fields close to 90° or 270°. On
the other hand, small differences in gamma passing
rates between two dosimeters were observed for spine
SABR and liver SABR of the TrueBeam STx and liver
IMRT plans of Trilogy, which used fields close to 0°
and 180°. The lower gamma passing rates of the
MapCHECK2 dosimeter, compared to those of the
ArcCHECK dosimeter, were due to dosimeter
characteristics.
The DynaLog file is a record of actual motor values
with an update rate of 50 ms. The motor values are
converted to MLC position values using a conversion
table (mlctable.txt). The Trajectory file is a record of
the direct MLC position values, with an update rate of
20 ms [30]. The information of the Trajectory file is
more accurate than that of the DynaLog file, owing to
the short record time and direct-record method [21,
32–34]. With respect to HN IMRT plans, the Trilogy
MLC errors were much larger than those of the True-
Beam STx system, but the gamma passing rates of the
TrueBeam STx system were smaller and as low as
Table 4 Correlations between global gamma passing rates with various gamma criteria and the modulation indices for intensity
modulated radiation therapy plans of Trilogy (p ≤ 0.05)
3%/3 mm 2%/2mm 2%/1mm 1%/2mm
rs p rs p rs p rs p
MI MapCHECK2
MIs −0.398 < 0.001 −0.386 < 0.001 − 0.347 < 0.001 − 0.323 0.001
MIa −0.302 0.002 −0.305 0.002 −0.397 < 0.001 − 0.210 0.034
MIc, IMRT −0.315 < 0.001 −0.320 < 0.001 − 0.400 < 0.001 − 0.230 0.006
MCS 0.391 < 0.001 0.347 < 0.001 0.377 < 0.001 0.272 0.004
PA −0.482 < 0.001 − 0.428 < 0.001 −0.655 < 0.001 − 0.286 < 0.001
PI −0.452 < 0.001 − 0.427 < 0.001 − 0.475 < 0.001 − 0.348 < 0.001
PM −0.431 0.001 −0.420 0.001 −0.455 < 0.001 − 0.357 0.020
ArcCHECK
MIs −0.271 0.006 −0.346 < 0.001 −0.355 < 0.001 – –
MIa −0.364 < 0.001 −0.455 < 0.001 − 0.456 < 0.001 −0.273 0.006
MIc, IMRT −0.375 < 0.001 −0.471 < 0.001 − 0.472 < 0.001 −0.281 0.004
MCS 0.426 < 0.001 0.589 < 0.001 0.660 < 0.001 – –
PA −0.505 < 0.001 − 0.667 < 0.001 −0.739 < 0.001 − 0.370 < 0.001
PI −0.395 < 0.001 − 0.581 < 0.001 −0.663 < 0.001 – –
PM −0.410 < 0.001 −0.607 < 0.001 − 0.671 < 0.001 −0.198 0.046
Note: rs Spearman’s rho, MIs Modulation index considering multi-leaf collimator speed, MIa Modulation index considering multi-leaf collimator acceleration, MIc, IMRT
Modulation index considering multi-leaf collimator acceleration and field aperture irregularity for intensity modulated radiation therapy, MCS Modulation
complexity score, PA Plan-averaged beam area, PI Plan-averaged beam irregularity, PM Plan-averaged beam modulation
Table 5 Correlations of the averaged multi-leaf collimator
positional errors to the modulation indices (p≤ 0.05)
TrueBeam STx Trilogy
rs p rs p
MIs 0.411 < 0.001 0.213 0.032
MIa 0.783 < 0.001 0.489 < 0.001
MIc, IMRT 0.887 < 0.001 0.504 < 0.001
MCS – – −0.727 < 0.001
PA 0.841 < 0.001 0.909 < 0.001
PI 0.861 < 0.001 0.767 < 0.001
PM – – 0.751 < 0.001
Note: rs Spearman’s rho, MIs Modulation index considering multi-leaf collimator
speed, MIa Modulation index considering multi-leaf collimator acceleration, MIc,
IMRT Modulation index considering multi-leaf collimator acceleration and field
aperture irregularity for intensity modulated radiation therapy, MCS
Modulation complexity score, PA Plan-averaged beam area, PI Plan-averaged
beam irregularity, PM Plan-averaged beam modulation
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11.5% of those of the Trilogy system, which were
contradictory results to each other. Therefore, a direct
absolute comparison between the DynaLog and Trajec-
tory files seems inappropriate, since the recording sys-
tems differ. At the very least, we could identify the
degree of IMRT plan modulation for various treatment
sites within a single linac system.
For TrueBeam STx with the MapCHECK2, the PI
showed the highest rs value for gamma passing rates
with 2%/2mm, 2%/1mm and 1%/2mm (rs = − 0.591 with
p < 0.001, rs = − 0.550 with p < 0.001 and rs = − 0.474 with
p < 0.001, respectively). For the ArcCHECK measure-
ments, the rs values of the PI were − 0.545 and − 0.677 for
gamma passing rates with 2%/2mm and 1%/2mm (all
with p < 0.001), showing the second highest correlations.
For the Trilogy system with the MapCHECK2, PI showed
the second highest rs values for every passing rate gamma
criterion (all with p < 0.001). For ArcCHECK measure-
ments, the moderately strong correlations were observed
between PI and the gamma passing rates with 2%/2mm
and 2%/1mm (rs = − 0.581 with p < 0.001 and rs = − 0.663
with p < 0.001). By reviewing the results of the correlation
analysis, PI mostly showed the first or second strongest
correlations with every gamma passing rate, regardless of
gamma criteria with the MapCHECK2 dosimeter, in both
TrueBeam STx and Trilogy results (all with p < 0.001). Al-
though the PI did not show the best performance with the
ArcCHECK measurements, it showed moderately strong
correlations with the gamma passing rates from the Arc-
CHECK measurements.
In the present study, the first attempt was made to
evaluate performance of the previously developed MIs
for IMRT by analyzing correlations of MIs with various
plan delivery accuracy measures. By utilizing a large
number of IMRT plans, various treatment sites, mul-
tiple photon energies and linac types, and multiple do-
simeters, the correlations in this study were not as high
as those found in earlier studies [3, 14, 16, 31]. Among
various modulation indices, the PI showed moderately
strong correlations with every plan delivery accuracy
measure. Therefore, the PI seems to be used to verify
IMRT plan delivery accuracy at the planning level in
the clinical setting. Furthermore, it has a potential to be
integrated in the treatment planning system (TPS) to
generate IMRT plans with high delivery accuracy. It is
expected to reduce resources in the clinical settings.
Although this study was expanded to comprehensively
examine the performance of MIs as predictors of IMRT
delivery accuracy by utilizing various treatment sites,
photon beam energies, and dosimeters, the results were
limited to only Varian linacs. This is a limitation of the
present study. To acquire more comprehensive results,
further study will be conducted by utilizing various types
of linac from various manufacturers in the future.
Conclusions
The PI value showed best performance, among the
modulation indices that were evaluated in this study, as
a predictor of IMRT plan delivery accuracy showing
strong correlations with various measures of IMRT de-
livery accuracy. The PI value could support the verifica-
tion of IMRT plan delivery accuracies before patient
treatment and reduce resource consumption in the
clinic, as it can be calculated at the planning level.
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